Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
NIH Grants (Human Papillomavirus)
Canine Oral Papillomavirus--Model for a Vaccine
September 28th, 1998
Project Number: 5 R01 CA57994-06. Grant Expires: 2 Fiscal Years. Principal Investigator: Schlegel, Richard. Performing Organization: Georgetown University. Abstract: "Papillomaviruses play a critical role in inducing malignant epithelial tumors of the oral and genital tract in humans. In our first grant awarded by the National Cancer Institute, we developed a canine model for evaluating the efficacy of vaccines in preventing infection by a mucosotropic papillomavirus (COPV). Our results indicated that the systemic administration of an L1 capsid protein vaccine was completely effective in preventing oral tumors. In addition, the studies...
Source: Women's Health Weekly (1998-09-28)
|
|
Advertisement |
|
|
